CMEs for the Kharrazian Institute Courses (USA)

The Kharrazian Institute has CME credits available (USA only) for each of the following 5 courses beginning October 1, 2023. See details and accredited hours for each course below. After completing the accredited course(s), order CME certificate at orange button below. Please bookmark this page for future access. 

Activity Description 

The last decade of research has focused on the gut microbiome, the gut-brain axis, and gut health in general. Disruption in these pathways can lead to chronic gastrointestinal issues, depression, changes in cognitive function, chronic autoimmune and inflammatory disorders, and various types of brain-based disorders.

This course explains how to evaluate the health of the gastrointestinal tract and the microbiota, their relationship to the brain and their impact on many common health disorders. You will learn brain rehabilitation strategies in addition to dietary, nutritional, and lifestyle factors that influence the gut-brain-body relationship

Target Audience: 

This activity is intended for healthcare professionals who manage patients with or at risk of gastrointestinal dysfunction.

Learning Objectives:

Upon completion of this activity, learners will be able to:

• Discuss the physiological web of the gastrointestinal tract and its impact on human health
• Review how to clinical identify digestive imbalances
• Discuss microbiome functions and diet, lifestyle, and metabolic factors that impact the microbiome, as well as the microbiome-axis interactions with the brain, skin, endocrine system, respiratory systems, and the immune system
• Outline clinical mechanisms to evaluate unresponsive GI conditions

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and the Kharrazian Institute. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 5.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.

Method of Participation:

This certified activity will take approximately 5.5 hours to complete. To receive credit, learners are required to view the following modules:

• Part 1: Session 1 – A Comprehensive Review of How the Gastrointestinal System Works and How it Impacts Human Health (90 mins)
• Part 1: Session 2 – The Clinical Mechanisms of Digestive Dysfunction (90 mins)
• Part 1: Session 4 – The Microbiome and Its Specific Applications to Clinical Practice (60 mins)
• Part 2: Session 7 – Clinical Mechanisms for Unresponsive and Chronic Gastrointestinal Disorders (90 mins)

Following participation, learners are required to complete the course evaluation. A certificate will be immediately available. There is no fee for the generation of the certificate.

For questions, contact Katlyn Cooper at kcooper@achlcme.org

Agenda

Activity Description

No two autoimmune disease patients are identical, even if they have the same autoimmune disease.

This course covers a basic landscape of autoimmunity including variations and differences between one patient and the next, different presentations with the same autoimmune disease, and different outcomes of different autoimmune diseases.

Target Audience: 

This activity is intended for healthcare professionals who manage patients with or at risk of autoimmune disease.

Learning Objectives:

Upon completion of this activity, learners will be able to:

• Outline a basic review of immunology and autoimmunity
• Review the fundamental concepts of autoimmunity

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and the Kharrazian Institute. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.

Method of Participation:

This certified activity will take approximately 3 hours to complete. To receive credit, learners are required to view the following modules:

• Part 1: Session 1 – Review of Basic Immunology and Autoimmunity (90 mins)
• Part 1: Session 2 – The Fundamental Concepts of Autoimmunity (90 mins)

Following participation, learners are required to complete the course evaluation. A certificate will be immediately available. There is no fee for the generation of the certificate.

For questions, contact Katlyn Cooper at kcooper@achlcme.org

Agenda

Activity Description

This course covers the pathophysiology of different types of blood sugar disorders with a focus on insulin resistance, progressing all the way from postprandial surges to metabolic syndrome, into diabetes and diabetes with complications. Following is a review of the spectrum of different degrees of hypoglycemia as well as different variations of autoimmune diabetes.

Target Audience

This activity is intended for healthcare professionals who manage patients with or at risk of diabetes or dysglycemia.

Learning Objectives:

Upon completion of this activity, learners will be able to:

• Discuss the clinical presentation, epidemiology, a pathophysiology of diabetes and blood sugar disorders
• Review the various types of dysglycemia and diagnostic criteria for diabetes and blood sugar disorders
• Discuss dysfunctions of the physiological web of blood sugar stability, glucose-brain interactions, glucose-endocrine interactions, glucose-immune interactions, and physiological alterations with dysglycemia
• Outline the role of diet and lifestyle factors on diabetes and dysglycemia
• Review pathogens associated with diabetes and laboratory tests to evaluate environmental triggers for diabetes
• Describe how to perform a comprehensive evaluation of blood sugar disorders

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and the Kharrazian Institute. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.

Method of Participation:

This certified activity will take approximately 7.5 hours to complete. To receive credit, learners are required to view the following modules:

• Part 1: Session 1 – Introduction and Pathophysiology of Diabetes and Dysglycemia (90 mins)
• Part 1: Session 2 – The Physiological Web of Diabetes and Dysglycemia (90 mins)
• Part 1: Session 3 – Diet, Nutrition, and Lifestyle Interventions for Diabetes and Dysglycemia (90 mins)
• Part 2: Session 7 – Environmental and Pathogenic Triggers for Type 1 and II Diabetes (90 mins)
• Part 2: Session 8 – How to Perform a Comprehensive Evaluation of Blood Sugar Disorders (90 mins)

Following participation, learners are required to complete the course evaluation. A certificate will be immediately available. There is no fee for the generation of the certificate.

For questions, contact Katlyn Cooper at kcooper@achlcme.org

Agenda

Activity Description

This course provides a review of mitochondrial function, the biology of making energy and the variables that impact adenosine triphosphate (ADP) production. Following is a detailed approach to evaluate clinical fatigue, understand how to objectively grade fatigue with standardized forms, and review key physical exam findings of fatigue syndromes. Additional topics of discussion include connections and research between how fatigue leads to pain syndromes.

Target Audience:

This activity is intended for healthcare professionals who manage patients with or at risk of chronic fatigue or chronic pain.

Learning Objectives:

Upon completion of this activity, learners will be able to:

• Reivew mitochondria bioenergetics and clinical mechanisms that impact cellular mitochondria bioenergetics
• Discuss medical history, examination, and laboratory analyses to identify mechanisms leading to chronic fatigue syndromes
• Discuss the cellular and physiological relationships between fatigue, depression, and mitochondria bioenergetics

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and the Kharrazian Institute. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.

Method of Participation:

This certified activity will take approximately 4 hours to complete. To receive credit, learners are required to view the following modules:

• Part 1: Session 1 – Introduction to Cellular and Physiological Bioenergetics (90 mins)
• Part 1: Session 2 – Clinical Evaluation of Fatigue Syndromes (90 mins)
• Part 1: Session 4 – The Connection Between Fatigue, Depression, and Pain Syndromes (60 mins)

Following participation, learners are required to complete the course evaluation. A certificate will be immediately available. There is no fee for the generation of the certificate.

For questions, contact Katlyn Cooper at kcooper@achlcme.org

Agenda

Activity Description

This course covers an introduction to peripheral arterial diseases, heart disease, and different forms of strokes and transient ischemic attacks (TIAs) that commonly occur followed by risk factors and a review of the pathophysiological web of vascular disease. The discussion also includes a literature review of supplements studied to impact cardiovascular disease.

Target Audience:

This activity is intended for healthcare professionals who manage patients with or at risk of cardiovascular rand neurovascular syndromes.

Learning Objectives:

Upon completion of this activity, learners will be able to:

• Review cardiovascular and neurovascular syndromes presented in clinical practice and clinical limitations and strengths of conventional and alternative medicine clinical models
• Review normal vascular endothelial function and review pathophysiology of vascular disease
• Discuss physiological and clinical risk factors that promote vascular disease, vicious cycles involved with vascular disease, and the impact of vascular disease on systems biology
• Outline a literature review of nutraceuticals that may impact vascular health

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and the Kharrazian Institute. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.

Method of Participation:

This certified activity will take approximately 6 hours to complete. To receive credit, learners are required to view the following modules:

• Part 1: Session 1 – Introduction to Cardiovascular and Neurovascular Syndromes (90 mins)
• Part 1: Session 2 – Vascular Pathophysiology (90 mins)
• Part 1: Session 3 – The Physiological Web of Vascular Disease (90 mins)
• Part 1: Session 4 – Nutraceuticals that Impact Vascular Health (60 mins)
• Part 1: Session 5 – Review of Part 1 and Questions (30 mins)

Following participation, learners are required to complete the course evaluation. A certificate will be immediately available. There is no fee for the generation of the certificate.

For questions, contact Katlyn Cooper at kcooper@achlcme.org

Agenda

Alternatively, if you are interested in the all access Kharrazian Institute Subscription, please signup at the button above. Then you would have access to all 13 KI courses.

IMPORTANT: There are two options for receiving the ACHL certificate and the accredited CME credits for each course (see accredited hours for each course above). You can either complete the accredited portions of any course and complete the required evaluation, or if you want to also receive the KI Certification of Completion (12 hours of participation) and the ACHL CME certificate (see accredited hours for each course above), you must complete watching all videos and pass both exams for each course, and complete the required evaluation.

EACH CME REQUEST TAKES AN HOUR TO PROCESS SO MULTIPLE REQUESTS IN ONE HOUR WILL FAIL. BEST PRACTICE IS TO REQUEST THE CME CERTIFICATE RIGHT AFTER YOU COMPLETE THE ACCREDITED PORTIONS OF EACH COURSE AND COMPLETE THE EVALUATION, OR AFTER YOU RECEIVE THE KI CERTIFICATE OF COMPLETION AND COMPLETE THE EVALUATION.

If you completed the KI Course prior to October 1, 2023, you would have to repeat the course to receive CME credit. Contact us HERE if you have not received the certificate(s) after completing the course according to your preference (2 options above).

Expiration

The expiration date of CMEs will be October 1, 2024. The CMEs are valid for USA practitioners only. If you have already completed the course prior to October 1, 2023, there is no retroactive credit available. You would have to complete the course again to receive credits.

Joint Providership Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and the Kharrazian Institute. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Disclaimer

The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Faculty

Datis Kharrazian, PhD, DHSc, DC, MS, MMSc, FACN
Associate Clinical Professor
Loma Linda University School of Medicine
Director, Kharrazian Institute, San Diego, CA

Faculty Disclosures

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with all ineligible companies. All relevant financial relationships have been mitigated prior to this activity.

The following financial relationships have been provided:

Datis Kharrazian, PhD, DHSc, DC, MS, MMSc, FACN
Scientific Advisory Board: Apex Energetics, Cyrex Labs
Royalty Recipient: Apex Energetics, Cyrex Labs

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: In the United States, nutraceuticals are not recognized as legitimate pharmacologic agents, and hence have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Staff and Reviewer Disclosures

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Providership

Provided by the Academy for Continued Healthcare Learning (ACHL) and the Kharrazian Institute.